BioCentury | Jun 29, 2009
Financial News

Intrexon financial update

...series C-2 round, bringing the total raised in the round to $35 million. Third Security's New River Management...
BioCentury | Jun 24, 2009
Financial News

Intrexon raises $10 million

...series C-2 round, bringing the total raised in the round to $35 million. Third Security's New River Management...
BioCentury | Feb 27, 2009
Financial News

Clinical Data raises $50M in note deal

...Data (NASDAQ:CLDA) raised $50 million through the sale of unsecured convertible notes due 2017 to New River Management...
BioCentury | May 9, 2008
Financial News

Intrexon raises $25 million

...series C financing, bringing the total raised in the round to $55 million. Third Security's New River Management...
BioCentury | Dec 3, 2007
Company News

Clinical Data, Vital Diagnostics B.V. deal

...sold its Vital Diagnostics Pty. subsidiary to Adrian Tennyenhuis, the subsidiary's general manager, and to New River Management...
...$1 million. The subsidiary later became Vital Diagnostics B.V., which is funded and controlled by New River Management...
BioCentury | Aug 6, 2007
Finance

Ebb & Flow

...Partners; Alliance Technology Ventures; Tullis-Dickerson; and Excelsior Venture Partners. Fund watch Third Security closed its New River Management...
...The firm will continue to invest in public and private life science and IT companies. New River Management...
BioCentury | Aug 2, 2007
Financial News

Third Security closes $250M fund

...Third Security closed its New River Management V fund at $250 million. The firm said the fund has...
BioCentury | May 16, 2007
Financial News

Intrexon raises $25 million

...Va.) raised $25 million in the second closing of a series C round, in which New River Management...
...Last August, Intrexon raised $5 million in the first closing of the round, in which New River Management...
BioCentury | Apr 25, 2007
Financial News

Halozyme raises $32.1 million

...a 2% premium to HTI's close of $8.95 on Monday. The shares were sold to New River Management...
BioCentury | Jan 29, 2007
Company News

New River management update

New River Pharmaceuticals Inc. (NRPH), Radford, Va. Business: Drug delivery, Neurology, Endocrine Hired: James Shaffer as VP of sales and marketing, formerly senior director of commercial operations at Prestwick Pharmaceuticals Inc. WIR Staff Neurology...
Items per page:
1 - 10 of 13
BioCentury | Jun 29, 2009
Financial News

Intrexon financial update

...series C-2 round, bringing the total raised in the round to $35 million. Third Security's New River Management...
BioCentury | Jun 24, 2009
Financial News

Intrexon raises $10 million

...series C-2 round, bringing the total raised in the round to $35 million. Third Security's New River Management...
BioCentury | Feb 27, 2009
Financial News

Clinical Data raises $50M in note deal

...Data (NASDAQ:CLDA) raised $50 million through the sale of unsecured convertible notes due 2017 to New River Management...
BioCentury | May 9, 2008
Financial News

Intrexon raises $25 million

...series C financing, bringing the total raised in the round to $55 million. Third Security's New River Management...
BioCentury | Dec 3, 2007
Company News

Clinical Data, Vital Diagnostics B.V. deal

...sold its Vital Diagnostics Pty. subsidiary to Adrian Tennyenhuis, the subsidiary's general manager, and to New River Management...
...$1 million. The subsidiary later became Vital Diagnostics B.V., which is funded and controlled by New River Management...
BioCentury | Aug 6, 2007
Finance

Ebb & Flow

...Partners; Alliance Technology Ventures; Tullis-Dickerson; and Excelsior Venture Partners. Fund watch Third Security closed its New River Management...
...The firm will continue to invest in public and private life science and IT companies. New River Management...
BioCentury | Aug 2, 2007
Financial News

Third Security closes $250M fund

...Third Security closed its New River Management V fund at $250 million. The firm said the fund has...
BioCentury | May 16, 2007
Financial News

Intrexon raises $25 million

...Va.) raised $25 million in the second closing of a series C round, in which New River Management...
...Last August, Intrexon raised $5 million in the first closing of the round, in which New River Management...
BioCentury | Apr 25, 2007
Financial News

Halozyme raises $32.1 million

...a 2% premium to HTI's close of $8.95 on Monday. The shares were sold to New River Management...
BioCentury | Jan 29, 2007
Company News

New River management update

New River Pharmaceuticals Inc. (NRPH), Radford, Va. Business: Drug delivery, Neurology, Endocrine Hired: James Shaffer as VP of sales and marketing, formerly senior director of commercial operations at Prestwick Pharmaceuticals Inc. WIR Staff Neurology...
Items per page:
1 - 10 of 13